Author:
Marshall Elena,Robertson Matt,Kam Satu,Penwarden Alison,Riga Paraskevi,Davies Nigel
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y. Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol. 2012;42:145–53.
2. National Institute for Health and Care Excellence (NICE) 2020, Hydroxychloroquine sulfate, NICE, https://bnf.nice.org.uk/drug/hydroxychloroquine-sulfate.html.
3. Pearce FA, Grainge MJ, King AJ, Lanyon PC. Implementing screening for hydroxychloroquine ocular toxicity: how big is the problem? Epidemiology of hydroxychloroquine prescriptions in the UK clinical practice research datalink. Rheumatology. 2019;58:kez105.037.
4. Yates M, Malaiya R, Stack J, Galloway JB. Hydroxychloroquine use: the potential impact of new ocular screening guidelines. Eye. 2018;32:161–2.
5. Tang C, Godfrey T, Stawell R, Nikpour M. Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects. Intern Med J. 2012;42:968–78.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献